Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation

Europace

Volumn 16, Issue 9, 2014, Pages 1291-1295

  Tieleman, R G ^a   Plantinga, Y ^a   Rinkes, D ^a   Bartels, G L ^a   Posma, J L ^a   Cator, R ^b   Hofman, C ^b   Houben, R P ^c  

^a MARTINI HOSPITAL   (Netherlands)

^b General Practitioners Molenweg   (Netherlands)

^c MyDiagnostick Medical BV   (Netherlands)

Author keywords

Atrial fibrillation; Electrocardiogram; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DIAGNOSTIC DEVICE; ELECTROCARDIOGRAM; FALSE POSITIVE RESULT; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART RHYTHM; HEART VENTRICLE EXTRASYSTOLE; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; P WAVE; PRIORITY JOURNAL; QRS COMPLEX; SENSITIVITY AND SPECIFICITY; SINUS ARRHYTHMIA; SINUS RHYTHM; VALIDATION STUDY; ATRIAL FIBRILLATION; COMPUTER ASSISTED DIAGNOSIS; DEVICE FAILURE ANALYSIS; DEVICES; ELECTROCARDIOGRAPHY; ELECTRONICS; EQUIPMENT DESIGN; EVALUATION STUDY; MASS SCREENING; PROCEDURES; REPRODUCIBILITY; SIGNAL PROCESSING;

AGED; ATRIAL FIBRILLATION; DIAGNOSIS, COMPUTER-ASSISTED; ELECTROCARDIOGRAPHY, AMBULATORY; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FEMALE; HUMANS; MALE; MASS SCREENING; MINIATURIZATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 84906968623     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu057     Document Type: Article

References (21)

1. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006;27:949-53.
2. Lowres N, Neubeck L, Redfern J, Freedman SB. Community screening programs to identify unknown atrial fibrillation: a systematic review. Eur Heart J 2012;33:61.
3. Deif B, Lowres N, Freedman SB. Screening for atrial fibrillation above age 65 detects an asymptomatic subset at high risk of stroke. Int J Cardiol 2013;164:371-2.
4. Healey JS, Connolly S, Gold MR, Israel CW, Van Gelder IC, Capucci A et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366:120-9.
5. Pisters R, van Oostenbrugge RJ, Knottnerus IL, de Vos CB, Boreas A, Lodder J et al. The likelihood of decreasing strokes in atrial fibrillation patients by strict application of guidelines. Europace 2010;12:779-84.
6. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51.
7. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883-91.
8. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981-92.
9. Dobreanu D, Svendsen JH, Lewalter T, Hernández-Madrid A, Lip GY, Blomström-Lundqvist C. Scientific Initiatives Committee, European Heart Rhythm Association. Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey. Europace 2013;15:1223-5.
10. Kaufman ES, Waldo AL. The impact of asymptomatic atrial fibrillation. J Am Coll Cardiol 2004;43:53-4. (Pubitemid 38045915)
11. Kinlay S, Leitch JW, Neil A, Chapman BL, Hardy DB, Fletcher PJ. Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with palpitations. A controlled clinical trial. Ann Intern Med 1996;124:16-20. (Pubitemid 26019619)
12. Liao J, Khalid Z, Scallan C, Morillo C, O'Donnell M. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke 2007;38:2935-40. (Pubitemid 350035686)
13. Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke 2004;35:1647-51. (Pubitemid 38823640)
14. Barthélémy JC, Féasson-Gérard S, Garnier P, Gaspoz JM, Da Costa A, Michel D. Automatic cardiac event recorders reveal paroxysmal atrial fibrillation after unexplained strokes or transient ischemic attacks. Ann Noninvasive Electrocardiol 2003;8:194-9. (Pubitemid 38569976)
15. Doliwa Sobocinski P, Anggårdh Rooth E, Frykman Kull V, von Arbin M, Wallén H, Rosenqvist M. Improved screening for silent atrial fibrillation after ischaemic stroke. Europace 2012;14:1112-6.
16. Hendriks JM, de Wit R, Crijns HJ, Vrijhoef HJ, Prins MH, Pisters R et al. Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation. Eur Heart J 2012;33:2692-9.
17. Lau JK et al. iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke. Int J Cardiol 2013;165:193-4.
18. Wiesel J, Fitzig L, Herschman Y, Messineo FC. Detection of atrial fibrillation using a modified microlife blood pressure monitor. Am J Hypertens 2009;22:848-52.
19. Kamel H, Hegde M, Johnson DR, Gage BF, Johnston SC. Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke. Stroke 2010;41:1514-20.
20. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010;12:1360-420.
21. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14:1385-413.